Study to Assess the Safety, Tolerability, and Pharmacokinetics (movement of drugs within the body) of AZD2693 in Healthy Participants

Trial Identifier:	D7830C00006
Sponsor:	AstraZeneca
NCTID::	NCT05107336
Start Date:	November 2021
Primary Completion Date:	March 2023
Study Completion Date:	March 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Sumida-ku, JP, 130-0004

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.